Healthcare providers who work with adolescents with diabetes are in an ideal position to provide education and support regarding contraceptive issues. Diabetes educators and other health professionals who counsel teens focus on other aspects of diabetes care and management but frequently do not address sexual issues or assess contraceptive practices. The purpose of this paper is to review oral contraceptive issues for teens with diabetes and to provide practice implications for health professionals who are in a favorable position to influence the quality of diabetes and general health care for these adolescents.
Get full access to this article
View all access options for this article.
References
1.
Fennoy 1. Contraception and the adolescent diabetic. Health Educ1989;20(6):21-31.
2.
Mills J.Baker L.Goldman A.Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes1979;28:292-93.
Mills J.Knowpp R.Simpson J. et al. Lack or relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med1988:318:671-76.
5.
Emans S.Goldstein D.Pediatric and adolescent gynecology. 3rd ed. Boston. Mass: Little, Brown & Co.1990.
6.
Jaskiewicz J.McAnarney E.Pregnancy during adolescence. Pediatr Rev1994:15(1):32-38.
7.
Centers for Disease Control.The contraception report. Atlanta, Ga: CDC. 1991;6(3):9.
8.
Eaton W.Mengel M.Mengel L.Larson D.Campbell R.Montague R.Psychosocial and psychopathologic influences on management and control of insulin-dependent diabetes. Int Psychiatr Med1992;22(2):105-17.
9.
Steel J.Prepregnancy counseling and contraception in the insulin dependent diabetic patient. Clin Obstet Gynerol1985:38(3):553-68.
10.
Steel J.Contraception, pregnancy and breast feeding in the insulin-dependent diabetic . Practitioner1987:231(9):1489-95.
11.
Wiese J.Osler M.Contraception in diabetic patients. Acta Endocrinol1974:182(suppl):87-94.
12.
Amiel S.Sherwin R.Simonson D.Lauritano A.Tamborlaine W.Impaired insulin action in puberty. N Engl J Med1086:315(4):215-19.
13.
Arslanian S.Ohki Y., Becker D.Drash A.The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents. Pediatr Res1992:31:203-6.
14.
Fontbonne A. , Basedevant A.Faguer B.Thomassin M.Buchsenschutz D.Contraceptive practice in 209 diabetic women regularly attending a specialized diabetes clinic. Diabetes Metab1987:3:411-15.
15.
St. James P.Younger M.Hamilton B.Waisbren S.Unplanned pregnancies in young women with diabetes: an analysis of psychosocial factors. Diabetes Carc1993.16(12):1572-78.
16.
Freinkel N.Metzger B., Potter J.Pregnancy in diabetes. In: Ellenberg M.Rifkin H. eds. Diabetes mellitus: theory and practice. 3rd ed. NY: Med Examination Publishing Co.1983:689-714.
17.
Jovanovic L.Druzin M.Peterson C.Effect of hyperglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects. Am J Med1981:71:921-27.
18.
Katzung B. ed. Basic and clinical pharmacology . 5th ed. Norwalk, Conn: Appleton & Lang. 1992:571.
19.
Jay M., Bridges C.Gottlieb R., DuRant R.Adolescent contraception: an overview. Adolesc Pediatr Gynecol1988;1:83-95.
20.
Patten B.Lenhard M.Contraceptive options and their effects on type I diabetes. Practical Diabetol1995:14(3):6-8.
21.
Brukman R.Strategies for reducing cardiovascular risk in women. J Reprod Med1991:36(suppl 3):238-46.
22.
Arnold A.Moodie D.Coronary artery disease in young women: risk factor unalysis and long-term follow-up. Cleveland Clin J Med1993; 60(5):393-98.
23.
Wantanabe R.Azen C.Roy S.Perlman J.Bergman R.Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. J Clin Endocrinol Metab1994;79(5):1277-83.
Beck D.Contraceptive steroids: modifications of carbohydrate and lipid metabolism . Metabolism1973;22:841-55.
26.
Miller G.Miller W.Plasma high-density lipoprotein concentrations and development of ischemic heart disease. Lanret1975:1:16-21.
27.
Wilbern T.Wearne K.Coronary heart disease incidence and cardiovascular mortality in Brusselton with reference glucose and insulin concentrations. Diabetes Care1979:303:81-87.
28.
Murad F.Kuret J.Estrogens and progestins. In: Gilman A.Rall T.Nies A.Taylor, eds. The pharmacological basis of therapeutics. Elmsford. NY: Pergamon Press. 1990:1384-412.
29.
Lane J.Connor J.The influence of endogenous and exogenous sex hormones in adolescents with attention to oral contraceptives and anabolic steroids. J Adolesc Health1994;15(8):630-34.
30.
Skouby S.Molsted-Pedersen L.Peterson K.Contraception for women with diabetes: an Update. Brailler's Clin Obstet Gynecol1991;5:493-503.
31.
Kmer K.Hagen C.Sando S.Eshoj O.Contraception in women with IDDM. Diabetes Care1992:15(11):1585-90.
32.
Petersen K.Skouby S.Sidelmann J.Moldsted-Petersen L.Jespersen J.Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol1994:171:400-5.
33.
Garg S.Chase H.Marshall G.Hoops S.Holmes D.Jackson W.Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA1994;271(14):1099-102.
34.
Klein B., Moss S., Klein R.Oral contraceptives in women with diabetes. Diabetes Care1990;13(8):895-97.
35.
Mathiesen E.Hommel E.Giese J.Parving H.Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuriaBr Med. J1991:303:81-87.
36.
Jonaitis M.Summary and commentary. Diabetes Specirum1995:8(3): 292-94.
37.
Cromer B.Enrile B., McCoy K., Gerhardstein M.Fitzpatrick M.Judis J.Knowledge, attitudes and behavior related to sexuality in adolescents with chronic disability. Dev Med Child Neurol1990 ;32:602-10.
38.
Rubin R.Summary and commentary. Diabetes Spectrum1995;8(3): 296-97.
39.
Ross M.Channon-Little L.Discussing sexuality: a guide for health practitioners. Australia: McLennon and Petty, 1991:3.
